In fact, some authors have evidenced that the GPR43 receptor on immune cells is involved in diverse inflammatory conditions, such as the secretion of IL-6 from macrophages exposed to SARS-CoV-2 membrane glycoprotein [58], atherosclerotic inflammation [59], gout [60], pneumoniae infection [61], diabetes [62], adipose tissue M2-type macrophages [63], and acute lung injury [64]. This evidence concerns the gene IL6 and diabetes mellitus.